Mary Keith
Hospice and Palliative Medicine · Gainesville, GANPI 1194073460
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 105 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 23 manufacturers reported payments, led by AbbVie at 26.2% of the total. Reporting peaked in 2021 at $826 and has fallen 95.6% since, to $36 in 2024.
Across 105 payments — averaging $15.08 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$415
- Amgen$252
- Boehringer Ingelheim$124
- Biohaven Pharmaceuticals, Inc.$110
- Paratek Pharmaceuticals, Inc.$106
- AstraZeneca$68
- plus $508 from 17 others
What the payments were for
- Food & beverage$1,584100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 35 | $415 |
| Amgen | 15 | $252 |
| Boehringer Ingelheim | 6 | $124 |
| Biohaven Pharmaceuticals, Inc. | 5 | $110 |
| Paratek Pharmaceuticals, Inc. | 7 | $106 |
| AstraZeneca | 5 | $68 |
| Esperion Therapeutics, Inc. | 4 | $66 |
| Dexcom, Inc. | 3 | $60 |
| Pfizer | 4 | $60 |
| Otsuka America Pharmaceutical, Inc. | 3 | $46 |
| Lilly USA, LLC | 3 | $37 |
| Merck | 2 | $29 |
| Genentech USA, Inc. | 2 | $27 |
| GSK | 2 | $25 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $22 |
| Abbott | 1 | $21 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $20 |
| Novo Nordisk | 1 | $19 |
| Cranial Technologies, Inc | 1 | $17 |
| Teva Pharmaceuticals USA, Inc. | 1 | $16 |
| Baxter Healthcare | 1 | $15 |
| Mylan Specialty L.p. | 1 | $15 |
| Collegium Pharmaceutical, Inc. | 1 | $14 |
How this compares
$1,584 in reported general payments places this provider in the 85th percentile of 69 hospice and palliative medicine providers in Georgia.
See all hospice and palliative medicine providers in Georgia →
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 13 | $185 |
| Oxycodone Hcl | 11 | $177 |
| Methadone Hcl | 13 | $108 |
Paid to pharmacies, not to this prescriber.
Other hospice and palliative medicine in Gainesville
- Frank LakeGainesville$363
- Noelle StanleyGainesville$152
- Adugnaw BekeleGainesville$79
- Veronica SudekumWarner Robins$7K
- Anthony EkwenchiAustell$5K
- Joshua JacksonAtlanta$5K
- Nokuthula MsimangaMarietta$3K
- Halima DaboikoKennesaw$3K
- Michelle ParkMarietta$2K
- Olumuyiwa AdeboyeLagrange$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.